CN110627732A - A method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof - Google Patents
A method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof Download PDFInfo
- Publication number
- CN110627732A CN110627732A CN201910966508.XA CN201910966508A CN110627732A CN 110627732 A CN110627732 A CN 110627732A CN 201910966508 A CN201910966508 A CN 201910966508A CN 110627732 A CN110627732 A CN 110627732A
- Authority
- CN
- China
- Prior art keywords
- nitro
- derivatives
- nitroquinoxaline
- aminoquinoxaline
- phenylenediamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- ZYYNLLHFNBENFK-UHFFFAOYSA-N 2-nitroquinoxaline Chemical compound C1=CC=CC2=NC([N+](=O)[O-])=CN=C21 ZYYNLLHFNBENFK-UHFFFAOYSA-N 0.000 title claims abstract description 35
- YOWAEZWWQFSEJD-UHFFFAOYSA-N quinoxalin-2-amine Chemical compound C1=CC=CC2=NC(N)=CN=C21 YOWAEZWWQFSEJD-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 18
- -1 mononitro-substituted o-phenylenediamine Chemical class 0.000 claims abstract description 30
- GPDKREBNFFEDHW-UHFFFAOYSA-N 1-(4-nitrophenyl)-2-phenylethane-1,2-dione Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)C(=O)C1=CC=CC=C1 GPDKREBNFFEDHW-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003054 catalyst Substances 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 29
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 29
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 14
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims description 11
- PPYORQPYERGTQF-UHFFFAOYSA-N 2-(4-aminophenyl)-3-phenylquinoxalin-6-amine Chemical compound NC1=CC=C(C=C1)C1=NC2=CC=C(C=C2N=C1C1=CC=CC=C1)N PPYORQPYERGTQF-UHFFFAOYSA-N 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- HXTVLOWYNRZFRT-UHFFFAOYSA-N 3-(4-aminophenyl)-2-phenylquinoxalin-6-amine Chemical compound C1(=CC=CC=C1)C1=NC2=CC=C(C=C2N=C1C1=CC=C(C=C1)N)N HXTVLOWYNRZFRT-UHFFFAOYSA-N 0.000 claims description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 8
- 239000007800 oxidant agent Substances 0.000 claims description 8
- RAUWPNXIALNKQM-UHFFFAOYSA-N 4-nitro-1,2-phenylenediamine Chemical compound NC1=CC=C([N+]([O-])=O)C=C1N RAUWPNXIALNKQM-UHFFFAOYSA-N 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- KNAFUNSPBQSTHS-UHFFFAOYSA-N 2-(4-nitrophenyl)-3-phenylquinoxalin-6-amine Chemical compound [N+](=O)([O-])C1=CC=C(C=C1)C1=NC2=CC=C(C=C2N=C1C1=CC=CC=C1)N KNAFUNSPBQSTHS-UHFFFAOYSA-N 0.000 claims description 6
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- MJQHNWJPXKKXEB-UHFFFAOYSA-N 3-(4-nitrophenyl)-2-phenylquinoxalin-6-amine Chemical compound [N+](=O)([O-])C1=CC=C(C=C1)C=1C(=NC2=CC=C(C=C2N1)N)C1=CC=CC=C1 MJQHNWJPXKKXEB-UHFFFAOYSA-N 0.000 claims description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 5
- SCCCFNJTCDSLCY-UHFFFAOYSA-N 1-iodo-4-nitrobenzene Chemical group [O-][N+](=O)C1=CC=C(I)C=C1 SCCCFNJTCDSLCY-UHFFFAOYSA-N 0.000 claims description 4
- 150000001555 benzenes Chemical class 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical group Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 3
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 claims description 3
- TVIYQSSPJDJMBL-UHFFFAOYSA-N 1-(3-nitrophenyl)-2-phenylethane-1,2-dione Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)C(=O)C=2C=CC=CC=2)=C1 TVIYQSSPJDJMBL-UHFFFAOYSA-N 0.000 claims description 2
- ZDFBKZUDCQQKAC-UHFFFAOYSA-N 1-bromo-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C=C1 ZDFBKZUDCQQKAC-UHFFFAOYSA-N 0.000 claims description 2
- SPUQPKUYSITLAF-UHFFFAOYSA-N 3,4,6-trimethyl-5-nitrobenzene-1,2-diamine Chemical compound CC=1C(=C(C(=C(C=1[N+](=O)[O-])C)C)N)N SPUQPKUYSITLAF-UHFFFAOYSA-N 0.000 claims description 2
- OIGSRUPCUMQCIF-UHFFFAOYSA-N 3,5-dimethyl-4-nitrobenzene-1,2-diamine Chemical compound CC1=CC(N)=C(N)C(C)=C1[N+]([O-])=O OIGSRUPCUMQCIF-UHFFFAOYSA-N 0.000 claims description 2
- BPFCOFUHPWJOQR-UHFFFAOYSA-N 3-methyl-4-nitrobenzene-1,2-diamine Chemical compound CC1=C(N)C(N)=CC=C1[N+]([O-])=O BPFCOFUHPWJOQR-UHFFFAOYSA-N 0.000 claims description 2
- IOCXBXZBNOYTLQ-UHFFFAOYSA-N 3-nitrobenzene-1,2-diamine Chemical compound NC1=CC=CC([N+]([O-])=O)=C1N IOCXBXZBNOYTLQ-UHFFFAOYSA-N 0.000 claims description 2
- CZGCEKJOLUNIFY-UHFFFAOYSA-N 4-Chloronitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1 CZGCEKJOLUNIFY-UHFFFAOYSA-N 0.000 claims description 2
- VBZQQOZFOSOFLO-UHFFFAOYSA-N 4-methyl-5-nitrobenzene-1,2-diamine Chemical compound CC1=CC(N)=C(N)C=C1[N+]([O-])=O VBZQQOZFOSOFLO-UHFFFAOYSA-N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 8
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 4
- 229940081974 saccharin Drugs 0.000 description 4
- 235000019204 saccharin Nutrition 0.000 description 4
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- JWCIMYGAABSRQD-UHFFFAOYSA-N 1-nitro-4-(2-phenylethynyl)benzene Chemical compound C1=CC([N+](=O)[O-])=CC=C1C#CC1=CC=CC=C1 JWCIMYGAABSRQD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- FYXZTVPBFJQFBO-UHFFFAOYSA-N 2-(4-nitrophenyl)acetyl chloride Chemical compound [O-][N+](=O)C1=CC=C(CC(Cl)=O)C=C1 FYXZTVPBFJQFBO-UHFFFAOYSA-N 0.000 description 2
- UDAIGHZFMLGNDQ-UHFFFAOYSA-N 2-nitroquinoline Chemical compound C1=CC=CC2=NC([N+](=O)[O-])=CC=C21 UDAIGHZFMLGNDQ-UHFFFAOYSA-N 0.000 description 2
- MLHIBZBUJGKYTK-UHFFFAOYSA-N 6-nitro-2-(4-nitrophenyl)-3-phenylquinoxaline Chemical compound [N+](=O)([O-])C1=CC=C(C=C1)C1=NC2=CC=C(C=C2N=C1C1=CC=CC=C1)[N+](=O)[O-] MLHIBZBUJGKYTK-UHFFFAOYSA-N 0.000 description 2
- MCPOVTPYRBJHDD-UHFFFAOYSA-N 6-nitro-3-(4-nitrophenyl)-2-phenylquinoxaline Chemical compound C1(=CC=CC=C1)C1=NC2=CC=C(C=C2N=C1C1=CC=C(C=C1)[N+](=O)[O-])[N+](=O)[O-] MCPOVTPYRBJHDD-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000003252 quinoxalines Chemical class 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- SOHAVULMGIITDH-ZXPSTKSJSA-N (1S,9R,14E)-14-(1H-imidazol-5-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione Chemical compound C([C@]1(C2=CC=CC=C2N([C@@]21NC1=O)OC)C(C)(C)C=C)=C(OC)C(=O)N2\C1=C\C1=CNC=N1 SOHAVULMGIITDH-ZXPSTKSJSA-N 0.000 description 1
- YBADLXQNJCMBKR-UHFFFAOYSA-N (4-nitrophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C([N+]([O-])=O)C=C1 YBADLXQNJCMBKR-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- ZHTXFOFNOCKVRR-UHFFFAOYSA-N 3-quinoxalin-2-yl-2H-1,2-benzoxazine Chemical compound N1=C(C=NC2=CC=CC=C12)C=1NOC2=C(C=1)C=CC=C2 ZHTXFOFNOCKVRR-UHFFFAOYSA-N 0.000 description 1
- XWCDSCYRIROFIO-UHFFFAOYSA-N 4-nitrobenzene-1,2-dicarboxamide Chemical compound NC(=O)C1=CC=C([N+]([O-])=O)C=C1C(N)=O XWCDSCYRIROFIO-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- SOHAVULMGIITDH-UHFFFAOYSA-N Oxaline Natural products O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)C=C(OC)C(=O)N2C1=CC1=CN=CN1 SOHAVULMGIITDH-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000005010 aminoquinolines Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0271—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds also containing elements or functional groups covered by B01J31/0201 - B01J31/0231
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4277—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
- B01J2231/4283—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using N nucleophiles, e.g. Buchwald-Hartwig amination
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
本申请涉及一种合成硝基喹喔啉或其衍生物的方法,其包括在存在催化剂邻苯甲酰磺酰亚胺的情况下,使单硝基取代的邻苯二胺或其衍生物与单硝基取代的苯偶酰或其衍生物在溶剂中反应预定时间段,得到所述硝基喹喔啉或其衍生物。本申请还提供一种合成氨基喹喔啉或其衍生物的方法。本申请还提供一种邻苯甲酰磺酰亚胺作为催化剂在合成硝基喹喔啉或其衍生物中的应用。本申请还提供一种制备4‑硝基苯偶酰的方法。本申请的合成工艺成本低、收率高,有助于实现大规模制备硝基喹喔啉或其衍生物以及氨基喹喔啉或其衍生物。
The present application relates to a method for synthesizing nitroquinoxaline or derivatives thereof, which comprises, in the presence of catalyst o-benzoylsulfonimide, making mononitro-substituted o-phenylenediamine or derivatives thereof and The mononitrosubstituted benzil or its derivatives are reacted in a solvent for a predetermined period of time to obtain the nitroquinoxaline or its derivatives. The present application also provides a method for synthesizing aminoquinoxaline or derivatives thereof. The application also provides an application of o-benzoylsulfonimide as a catalyst in the synthesis of nitroquinoxaline or its derivatives. The present application also provides a method for preparing 4-nitrobenzil. The synthesis process of the present application has low cost and high yield, and is helpful for large-scale preparation of nitroquinoxaline or its derivatives and aminoquinoxaline or its derivatives.
Description
技术领域technical field
本申请涉及有机合成技术领域,具体来说,本申请涉及一种合成硝基喹喔啉或其衍生物以及氨基喹喔啉或其衍生物的方法。The application relates to the technical field of organic synthesis, specifically, the application relates to a method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof.
背景技术Background technique
喹喔啉是一种具有优异生物活性和热稳定性的苯并吡嗪类化合物,因其存在于多种化合物中且有望用于染料、有机半导体、电致发光材料和阴离子受体等领域而受到了广泛的研究。类似地,喹喔啉衍生物也潜在地可应用许多领域。因此,本领域也开发了许多方法来合成喹喔啉衍生物,例如使含邻苯二胺结构的单体与α-羟基酮或环氧化物等反应。Quinoxaline is a benzopyrazine compound with excellent biological activity and thermal stability. It exists in a variety of compounds and is expected to be used in dyes, organic semiconductors, electroluminescent materials and anion acceptors has been extensively studied. Similarly, quinoxaline derivatives are also potentially applicable in many fields. Therefore, many methods have been developed in the art to synthesize quinoxaline derivatives, such as reacting o-phenylenediamine-containing monomers with α-hydroxy ketones or epoxides.
氨基喹喔啉具有较高的化学键能,较大的摩尔体积以及较弱的极性,这赋予了由其制备的聚合物优良的耐热性和抗氧化性能、较高的环境稳定性、低介电常数、介电损耗以及较高的塑性。氨基喹喔啉可在溶解于有机溶剂中,具有良好的加工性能。Aminoquinoxaline has higher chemical bond energy, larger molar volume and weaker polarity, which endows the polymer prepared by it with excellent heat resistance and oxidation resistance, higher environmental stability, low Dielectric constant, dielectric loss and high plasticity. Aminoquinoxaline can be dissolved in organic solvents and has good processing properties.
2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物是一种新型的氨基喹喔啉类二胺单体。使用该混合物合成的喹喔啉基聚酰亚胺、聚醚、聚酯等聚合物具有良好的热稳定性、化学稳定性和优异的导电性能,具有较好的透气性和韧性。此外,该混合物在有机溶剂中溶解性好,结晶性低,具有较宽的加工窗口。2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-aminophenyl)-2-phenyl-6-aminoquinoxaline mixture is a new type of amino Quinoxaline diamine monomer. Polymers such as quinoxaline-based polyimide, polyether and polyester synthesized by using the mixture have good thermal stability, chemical stability and excellent electrical conductivity, and have good air permeability and toughness. In addition, the mixture has good solubility in organic solvents, low crystallinity, and a wide processing window.
中国发明专利公开CN105153144A公开了一种主链双胺型喹喔啉基苯并噁嗪及其制备方法,其中公开了以4-硝基苯偶酰、4-硝基邻苯二胺和冰醋酸为起始原料,先合成2-(4-硝基苯基)-3-苯基-6-氨基喹喔啉和3-(4-硝基苯基)-2-苯基-6-氨基喹喔啉混合物,收率为81.%。然后,再经水合肼还原得到2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物。该专利文献披露工艺的不足之处在于合成硝基喹喔啉混合物时的收率不高,且所用的起始原料4-硝基苯偶酰价格昂贵不易得到,从而导致生产成本较高,不适合工业化生产。Chinese invention patent publication CN105153144A discloses a main chain diamine-type quinoxalinyl benzoxazine and a preparation method thereof, in which 4-nitrobenzil, 4-nitro-o-phenylenediamine and glacial acetic acid are disclosed As the starting material, first synthesize 2-(4-nitrophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-nitrophenyl)-2-phenyl-6-aminoquinoxaline Oxaline mixture, the yield is 81.%. Then, obtain 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-aminophenyl)-2-phenyl-6-aminoquinoxaline through hydrazine hydrate reduction morphine mixture. The weak point of this patent document disclosure technique is that the yield when synthesizing the nitroquinoxaline mixture is not high, and the starting material 4-nitrobenzil used is expensive and difficult to obtain, thus resulting in higher production cost, not Suitable for industrial production.
中国发明专利公开CN107089954A披露了一种合成2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物的方法,所述方法包括(1)以4-硝基苯乙酸为起始原料,经氯化反应得到4-硝基苯乙酰氯;(2)使4-硝基苯乙酰氯与苯反应得到2-(4-硝基苯基)-1-苯乙酮;(3)使2-(4-硝基苯基)-1-苯乙酮与4-硝基邻苯二胺反应得到2-(4-硝基苯基)-3-苯基-6-氨基喹喔啉和3-(4-硝基苯基)-2-苯基-6-氨基喹喔啉混合物;以及(4)对步骤(3)中的硝基喹喔啉混合物进行催化加氢,得到2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物。该专利文献披露的合成方法没有使用4-硝基苯偶酰,在一定程度上降低了生产成本。但是,该工艺中的步骤(3)需要于存在气态氧化剂和碱性催化剂的情况下在70-80℃的较高温度下进行,收率在90.1%-95.0%之间。Chinese invention patent publication CN107089954A discloses a kind of synthetic 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-aminophenyl)-2-phenyl-6-amino The method of quinoxaline mixture, described method comprises (1) take 4-nitrophenylacetic acid as starting material, obtain 4-nitrophenylacetyl chloride through chlorination; (2) make 4-nitrophenylacetyl chloride React with benzene to obtain 2-(4-nitrophenyl)-1-acetophenone; (3) make 2-(4-nitrophenyl)-1-acetophenone and 4-nitro-o-phenylenediamine The reaction obtains 2-(4-nitrophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-nitrophenyl)-2-phenyl-6-aminoquinoxaline mixture; and (4) carry out catalytic hydrogenation to the nitroquinoxaline mixture in step (3), obtain 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-amino Phenyl)-2-phenyl-6-aminoquinoxaline mixture. The synthesis method disclosed in this patent document does not use 4-nitrobenzil, which reduces the production cost to a certain extent. However, step (3) in this process needs to be carried out at a relatively high temperature of 70-80° C. in the presence of a gaseous oxidant and a basic catalyst, and the yield is between 90.1% and 95.0%.
为此,本领域持续需要开发一种低成本、高收率的合成硝基喹喔啉或其衍生物以及氨基喹喔啉或其衍生物的方法。For this reason, there is a continuous need in the art to develop a low-cost, high-yield method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof.
发明内容Contents of the invention
本申请之目的在于提供一种低成高收率的合成硝基喹喔啉或其衍生物的方法,从而解决上述现有技术中的技术问题。具体来说,本申请以4-硝基碘代苯和苯乙炔为起始原料,经济高效地合成4-硝基苯偶酰。然后,通过选用邻苯甲酰磺酰亚胺(亦称为糖精)作为特定催化剂,以高达98%的收率在常温常压下使4-硝基苯偶酰与4-硝基邻苯二胺反应来制备2-(4-硝基苯基)-3-苯基-6-氨基喹喔啉和3-(4-硝基苯基)-2-苯基-6-氨基喹喔啉混合物。最后,再通过催化加氢的方法来制备2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物。The purpose of this application is to provide a method for synthesizing nitroquinoxaline or its derivatives with low cost and high yield, so as to solve the technical problems in the above-mentioned prior art. Specifically, this application uses 4-nitroiodobenzene and phenylacetylene as starting materials to economically and efficiently synthesize 4-nitrobenzil. Then, by selecting o-benzoylsulfonimide (also known as saccharin) as a specific catalyst, 4-nitrobenzil and 4-nitrophthalamide can be synthesized with a yield of up to 98% at normal temperature and pressure. Amine reaction to prepare mixtures of 2-(4-nitrophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-nitrophenyl)-2-phenyl-6-aminoquinoxaline . Finally, 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-aminophenyl)-2-phenyl-6- Aminoquinoxaline mixtures.
本申请之目的还在于提供一种合成硝基取代的苯偶酰的方法。The purpose of this application is also to provide a method for synthesizing nitro-substituted benzil.
本申请之目的还在于提供一种合成氨基喹喔啉或其衍生物的方法。The purpose of the application is also to provide a method for synthesizing aminoquinoxaline or derivatives thereof.
本申请之目的还在于提供一种邻苯甲酰磺酰亚胺作为催化剂在制备硝基喹喔啉或其衍生物中的应用。The purpose of the present application is also to provide a kind of o-benzoylsulfonimide as a catalyst in the preparation of nitroquinoxaline or its derivatives.
本申请之目的还在于提供一种制备4-硝基苯偶酰的方法。The purpose of this application is also to provide a method for preparing 4-nitrobenzil.
为了解决上述技术问题,本申请提供下述技术方案:In order to solve the above technical problems, the application provides the following technical solutions:
在第一方面中,本申请提供一种合成硝基喹喔啉或其衍生物的方法,其特征在于,所述方法包括以下步骤:在存在催化剂邻苯甲酰磺酰亚胺的情况下,使单硝基取代的邻苯二胺或其衍生物与单硝基取代的苯偶酰或其衍生物在溶剂中反应预定时间段,得到所述硝基喹喔啉或其衍生物;In a first aspect, the application provides a method for synthesizing nitroquinoxaline or derivatives thereof, characterized in that the method comprises the following steps: in the presence of a catalyst o-benzoylsulfonimide, reacting mononitro-substituted o-phenylenediamine or its derivatives with mononitro-substituted benzil or its derivatives in a solvent for a predetermined period of time to obtain the nitroquinoxaline or its derivatives;
其中所述单硝基取代的邻苯二胺或其衍生物具有通过下述通式(I)所示的结构:Wherein said mononitro-substituted o-phenylenediamine or its derivatives have a structure shown by the following general formula (I):
在通式(I)中,基团R1、R2、R3和R4各自独立地选自H、C1-C10烷基或硝基,且基团R1、R2、R3和R4中的有且只有一种为硝基;In the general formula (I), the groups R1, R2, R3 and R4 are each independently selected from H, C1-C10 alkyl or nitro, and there is one and only one of the groups R1, R2, R3 and R4 for nitro;
其中,所述单硝基取代的苯偶酰具有通过下述通式(II)所示的结构:Wherein, the mononitro-substituted benzil has a structure shown by the following general formula (II):
在通式(II)中,基团R5、R6、R7、R8、R9、R10、R11、R12、R13和R14各自独立地选自H、C1-C10烷基或硝基,且基团R5、R6、R7、R8、R9、R10、R11、R12、R13和R14中有且只有一种为硝基;In the general formula (II), the groups R5, R6, R7, R8, R9, R10, R11, R12, R13 and R14 are each independently selected from H, C1-C10 alkyl or nitro, and the groups R5, One and only one of R6, R7, R8, R9, R10, R11, R12, R13 and R14 is nitro;
其中,所述硝基喹喔啉或其衍生物具有通过下述通式(III)所示的结构:Wherein, the nitroquinoxaline or its derivatives have the structure shown by the following general formula (III):
在通式(III)中,基团R21、R22、R23和R24各自独立地选自H、C1-C10烷基或硝基,且基团R21、R22、R23和R24中有且只有一种为硝基;在通式(III)中,基团R31、R32、R33、R34、R35、R41、R42、R43、R44和R45各自独立地选自H、C1-C10烷基或硝基,且基团R31、R32、R33、R34、R35、R41、R42、R43、R44和R45中有且只有一种为硝基。In the general formula (III), the groups R21, R22, R23 and R24 are each independently selected from H, C1-C10 alkyl or nitro, and only one of the groups R21, R22, R23 and R24 is Nitro; In general formula (III), group R31, R32, R33, R34, R35, R41, R42, R43, R44 and R45 are each independently selected from H, C1-C10 alkyl or nitro, and the group One and only one of groups R31, R32, R33, R34, R35, R41, R42, R43, R44 and R45 is nitro.
在第一方面的一种实施方式中,所述单硝基取代的苯偶酰或其衍生物包括4-硝基苯偶酰、3-硝基苯偶酰、2-甲基-4-硝基苯偶酰、3-甲基-4-硝基苯偶酰、2,3-二甲基-4-硝基苯偶酰、2,3,5-三甲基-4-硝基苯偶酰;In one embodiment of the first aspect, the mononitro-substituted benzil or its derivatives include 4-nitrobenzil, 3-nitrobenzil, 2-methyl-4-nitrobenzyl phenylil, 3-methyl-4-nitrobenzil, 2,3-dimethyl-4-nitrobenzil, 2,3,5-trimethyl-4-nitrobenzil Acyl;
和/或,所述单硝基取代的邻苯二胺或其衍生物为3-硝基邻苯二胺、4-硝基邻苯二胺、5-硝基邻苯二胺、6-硝基邻苯二胺、3-甲基-4-硝基邻苯二胺、5-甲基-4-硝基邻苯二胺、3,5-二甲基-4-硝基邻苯二胺或者3,5,6-三甲基-4-硝基邻苯二胺;And/or, the mononitro-substituted o-phenylenediamine or its derivatives are 3-nitro-o-phenylenediamine, 4-nitro-o-phenylenediamine, 5-nitro-o-phenylenediamine, 6-nitro O-phenylenediamine, 3-methyl-4-nitro-o-phenylenediamine, 5-methyl-4-nitro-o-phenylenediamine, 3,5-dimethyl-4-nitro-o-phenylenediamine or 3,5,6-trimethyl-4-nitro-o-phenylenediamine;
和/或,所述溶剂为冰乙酸、甲醇、N N-二甲基甲酰胺或者乙腈中的一种或几种。And/or, the solvent is one or more of glacial acetic acid, methanol, N N-dimethylformamide or acetonitrile.
在第一方面的一种实施方式中,以摩尔数为基准计,所述催化剂邻苯甲酰磺酰亚胺与单硝基取代的本偶酰的用量比例小于或等于5%。In an embodiment of the first aspect, based on the number of moles, the ratio of the amount of the catalyst o-benzoylsulfonimide to mononitro-substituted benzil is less than or equal to 5%.
在第一方面的一种实施方式中,所述硝基喹喔啉或其衍生物包括2-(4-硝基苯基)-3-苯基-6-氨基喹喔啉和3-(4-硝基苯基)-2-苯基-6-氨基喹喔啉混合物。In one embodiment of the first aspect, the nitroquinoxaline or its derivatives include 2-(4-nitrophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4 -nitrophenyl)-2-phenyl-6-aminoquinoxaline mixture.
在第一方面的一种实施方式中,所述4-硝基苯偶酰通过下述方法来制备:In one embodiment of the first aspect, the 4-nitrobenzil is prepared by the following method:
(1)使硝基卤代苯与苯乙炔反应,得到1-硝基-4-苯基乙炔;以及(1) reacting nitrohalogenated benzene with phenylacetylene to obtain 1-nitro-4-phenylacetylene; and
(2)在存在金属催化剂的情况下,使1-硝基-4-苯基乙炔与氧化剂反应,得到所述4-硝基苯偶酰。(2) reacting 1-nitro-4-phenylacetylene with an oxidizing agent in the presence of a metal catalyst to obtain the 4-nitrobenzil.
在第一方面的一种实施方式中,所述硝基卤代苯为4-硝基碘苯、4-硝基溴苯或4-硝基氯苯;In one embodiment of the first aspect, the nitrohalobenzene is 4-nitroiodobenzene, 4-nitrobromobenzene or 4-nitrochlorobenzene;
和/或,所述金属催化剂为二氯化钯,或者等摩尔量的氯化铝和醋酸钯的混合物;And/or, the metal catalyst is palladium dichloride, or a mixture of aluminum chloride and palladium acetate in equimolar amounts;
和/或,所述氧化剂为二甲亚砜。And/or, the oxidizing agent is dimethyl sulfoxide.
在第二方面中,本申请提供一种合成氨基喹喔啉或其衍生物的方法,其特征在于,所述方法包括对通过如权利要求1所述的合成硝基喹喔啉或其衍生物的方法所制备的硝基喹喔啉或其衍生物对应的硝基还原成氨基,得到所述氨基喹喔啉或其衍生物。In a second aspect, the application provides a method for synthesizing aminoquinoxaline or derivatives thereof, characterized in that, the method comprises the synthesis of nitroquinoxaline or derivatives thereof as claimed in claim 1 The corresponding nitro group of the nitroquinoxaline or its derivatives prepared by the method is reduced to an amino group to obtain the aminoquinoxaline or its derivatives.
在第二方面的一种实施方式中,所述氨基喹喔啉或其衍生物为2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物。In one embodiment of the second aspect, the aminoquinoxaline or derivatives thereof are 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-amino Phenyl)-2-phenyl-6-aminoquinoxaline mixture.
在第三方面中,本申请提供一种邻苯甲酰磺酰亚胺作为催化剂在合成硝基喹喔啉或其衍生物中的应用。In a third aspect, the present application provides an application of o-benzoylsulfonimide as a catalyst in the synthesis of nitroquinoxaline or its derivatives.
在第四方面中,本申请提供一种制备4-硝基苯偶酰的方法,所述方法包括以下步骤:In a fourth aspect, the present application provides a method for preparing 4-nitrobenzil, the method comprising the following steps:
(1)使硝基卤代苯与苯乙炔反应,得到1-硝基-4-苯基乙炔;以及(1) reacting nitrohalogenated benzene with phenylacetylene to obtain 1-nitro-4-phenylacetylene; and
(2)在存在金属催化剂的情况下,使1-硝基-4-苯基乙炔与氧化剂反应,得到所述4-硝基苯偶酰。(2) reacting 1-nitro-4-phenylacetylene with an oxidizing agent in the presence of a metal catalyst to obtain the 4-nitrobenzil.
与现有技术相比,本申请的有益效果在于本申请的合成工艺成本低、收率高,有助于实现大规模制备硝基喹喔啉或其衍生物以及氨基喹喔啉或其衍生物。Compared with the prior art, the beneficial effect of the present application is that the synthesis process of the present application has low cost and high yield, which helps to realize the large-scale preparation of nitroquinoxaline or its derivatives and aminoquinoxaline or its derivatives .
附图说明Description of drawings
图1显示1-硝基-4-苯基乙炔苯的氢谱核磁共振图谱。Figure 1 shows the H NMR spectrum of 1-nitro-4-phenylethynylbenzene.
图2显示4-硝基苯偶酰的氢谱核磁共振图谱。Figure 2 shows the H NMR spectrum of 4-nitrobenzil.
图3显示根据实施例1的摩尔比例为1:1的两种同分异构体2-(4-硝基苯基)-3-苯基-6-硝基喹喔啉和3-(4-硝基苯基)-2-苯基-6-硝基喹喔啉混合物的氢谱核磁共振图谱。Fig. 3 shows two isomers 2-(4-nitrophenyl)-3-phenyl-6-nitroquinoxaline and 3-(4 -Nitrophenyl)-2-phenyl-6-nitroquinoxaline mixture of the hydrogen spectrum nuclear magnetic resonance spectrum.
图4显示根据实施例1的摩尔比例为1:1的两种同分异构体2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物的氢谱核磁共振图谱。Figure 4 shows two isomers 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-amino The hydrogen spectrum nuclear magnetic resonance spectrum of the mixture of phenyl)-2-phenyl-6-aminoquinoxaline.
具体实施方式Detailed ways
氨基喹喔啉或其衍生物是一种新型二胺单体,利用其合成的聚酰亚胺、聚醚、聚酯等聚合物具有优异的热稳定性和化学稳定性。硝基喹喔啉或其衍生物是合成氨基喹喔啉或其衍生物的前体化合物,将硝基转换成氨基在业内已有成熟的工艺,例如催化加氢还原、水合肼还原等。但是,现有技术中合成硝基喹啉或其衍生物的工艺有的成本高昂,有的反应产率不高,有的反应条件苛刻。因此,本领域持续需要开发一种低成本、高收率的合成硝基喹喔啉或其衍生物的方法。Aminoquinoxaline or its derivatives are a new type of diamine monomer, and polymers such as polyimides, polyethers, and polyesters synthesized from them have excellent thermal and chemical stability. Nitroquinoxaline or its derivatives are precursor compounds for the synthesis of aminoquinoxaline or its derivatives. There are mature processes in the industry for converting nitro groups into amino groups, such as catalytic hydrogenation reduction, hydrazine hydrate reduction, etc. However, some processes for synthesizing nitroquinoline or its derivatives in the prior art have high costs, some reaction yields are not high, and some reaction conditions are harsh. Therefore, there is a continuous need in the art to develop a low-cost, high-yield method for synthesizing nitroquinoxaline or derivatives thereof.
本申请提供一种合成硝基喹喔啉或其衍生物的方法,其特征在于,所述方法包括以下步骤:在存在催化剂邻苯甲酰磺酰亚胺的情况下,使单硝基取代的邻苯二胺或其衍生物与单硝基取代的苯偶酰或其衍生物在溶剂中反应预定时间段,得到所述硝基喹喔啉或其衍生物;The application provides a method for synthesizing nitroquinoxaline or derivatives thereof, characterized in that the method comprises the following steps: in the presence of a catalyst o-benzoylsulfonimide, the mononitro-substituted o-Phenylenediamine or its derivatives react with mononitro-substituted benzil or its derivatives in a solvent for a predetermined period of time to obtain the nitroquinoxaline or its derivatives;
其中所述单硝基取代的邻苯二胺或其衍生物具有通过下述通式(I)所示的结构:Wherein said mononitro-substituted o-phenylenediamine or its derivatives have a structure shown by the following general formula (I):
在通式(I)中,基团R1、R2、R3和R4各自独立地选自H、C1-C10烷基或硝基,且基团R1、R2、R3和R4中的有且只有一种为硝基;In the general formula (I), the groups R1, R2, R3 and R4 are each independently selected from H, C1-C10 alkyl or nitro, and there is one and only one of the groups R1, R2, R3 and R4 for nitro;
其中,所述单硝基取代的苯偶酰具有通过下述通式(II)所示的结构:Wherein, the mononitro-substituted benzil has a structure shown by the following general formula (II):
在通式(II)中,基团R5、R6、R7、R8、R9、R10、R11、R12、R13和R14各自独立地选自H、C1-C10烷基或硝基,且基团R5、R6、R7、R8、R9、R10、R11、R12、R13和R14中有且只有一种为硝基;In the general formula (II), the groups R5, R6, R7, R8, R9, R10, R11, R12, R13 and R14 are each independently selected from H, C1-C10 alkyl or nitro, and the groups R5, One and only one of R6, R7, R8, R9, R10, R11, R12, R13 and R14 is nitro;
其中,所述硝基喹喔啉或其衍生物具有通过下述通式(III)所示的结构:Wherein, the nitroquinoxaline or its derivatives have the structure shown by the following general formula (III):
在通式(III)中,基团R21、R22、R23和R24各自独立地选自H、C1-C10烷基或硝基,且基团R21、R22、R23和R24中有且只有一种为硝基;在通式(III)中,基团R31、R32、R33、R34、R35、R41、R42、R43、R44和R45各自独立地选自H、C1-C10烷基或硝基,且基团R31、R32、R33、R34、R35、R41、R42、R43、R44和R45中有且只有一种为硝基。In the general formula (III), the groups R21, R22, R23 and R24 are each independently selected from H, C1-C10 alkyl or nitro, and only one of the groups R21, R22, R23 and R24 is Nitro; In general formula (III), group R31, R32, R33, R34, R35, R41, R42, R43, R44 and R45 are each independently selected from H, C1-C10 alkyl or nitro, and the group One and only one of groups R31, R32, R33, R34, R35, R41, R42, R43, R44 and R45 is nitro.
在一种具体实施方式中,通式(III)中的箭头表示同时存在两种同分异构体,具体指喹喔啉含氮六元环上2位和3位上的取代基互换构成的同分异构体的混合物。In a specific embodiment, the arrow in the general formula (III) indicates that there are two isomers at the same time, specifically referring to the exchange of substituents at the 2 and 3 positions on the nitrogen-containing six-membered ring of quinoxaline to form mixture of isomers.
如本文所使用,术语“C1-C10烷基”指碳原子数为1到10的直链或支化烷基。在一种具体实施方式中,C1-C10烷基包括甲基、乙基、丙基、异丙基、丁基、戊基、己基、庚基、辛基、壬基或癸基等。As used herein, the term "C1-C10 alkyl" refers to a straight chain or branched alkyl group having 1 to 10 carbon atoms. In a specific embodiment, the C1-C10 alkyl group includes methyl, ethyl, propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl or decyl and the like.
在一种特别优选地实施方式中,所述硝基喹啉或其衍生物为2-(4-硝基苯基)-3-苯基-6-氨基喹喔啉和3-(4-硝基苯基)-2-苯基-6-氨基喹喔啉混合物。In a particularly preferred embodiment, the nitroquinoline or derivatives thereof are 2-(4-nitrophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-nitroquinoxaline phenyl)-2-phenyl-6-aminoquinoxaline mixture.
在一种特别优选地实施方式中,所述氨基喹啉或其衍生物为2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物。In a particularly preferred embodiment, the aminoquinoline or derivatives thereof are 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-aminophenyl )-2-phenyl-6-aminoquinoxaline mixture.
在另一种实施方式中,本申请的发明人令人意外地发现通常作为甜味剂的邻苯甲酰磺酰亚胺(亦称糖精)在极低用量下即可显著提高单硝基取代的苯偶酰与单硝基取代的邻苯二胺之间反应的收率。In another embodiment, the inventors of the present application surprisingly found that o-benzoylsulfonimide (also known as saccharin), which is commonly used as a sweetener, can significantly increase the concentration of mononitro substitution at a very low dosage. The yield of the reaction between benzil and mononitro-substituted o-phenylenediamine.
本申请还提供一种经济高效地合成4-硝基苯偶酰的方法。所述方法可包括以下步骤:(1)使硝基卤代苯与苯乙炔反应,得到1-硝基-4-苯基乙炔;以及(2)在存在金属催化剂的情况下,使1-硝基-4-苯基乙炔与氧化剂反应,得到所述4-硝基苯偶酰。The present application also provides a cost-effective method for synthesizing 4-nitrobenzil. The method may comprise the steps of: (1) reacting nitrohalobenzene with phenylacetylene to obtain 1-nitro-4-phenylacetylene; and (2) reacting 1-nitrohalobenzene in the presence of a metal catalyst Base-4-phenylacetylene is reacted with an oxidizing agent to obtain the 4-nitrobenzil.
在一种具体实施方式中,苯偶酰的制备中氯化钯可用等摩尔量的氯化铝和醋酸钯替代,但是氯化铝和醋酸钯作催化剂的产率较低(40%左右)。In a specific embodiment, palladium chloride can be replaced by equimolar amounts of aluminum chloride and palladium acetate in the preparation of benzil, but the yield of aluminum chloride and palladium acetate as catalyst is low (about 40%).
在一种具体实施方式中,在不同温度和时长条件下不使用催化剂也可达到较高产率:冰乙酸作溶剂常温反应12h产率可达98%;甲醇作溶剂64℃加热回流下反应12h产率可达98%;DMF作溶剂90℃下反应36h产率可大于80%,乙腈作溶剂在90℃下反应36h产率可大于60%。冰乙酸作溶剂的条件下用糖精作为催化剂在5%的添加量下可缩短反应时间至1h。In a specific embodiment, a higher yield can be achieved without using a catalyst under different temperature and duration conditions: glacial acetic acid is used as a solvent at room temperature for 12 hours and the yield can reach 98%; The yield can reach 98%; the yield can be greater than 80% when DMF is used as a solvent at 90°C for 36 hours, and the yield can be greater than 60% when acetonitrile is used as a solvent for 36 hours at 90°C. Using saccharin as a catalyst under the condition of glacial acetic acid as a solvent can shorten the reaction time to 1 h under the addition of 5%.
实施例Example
下面将结合实施例,对本申请进行一步描述和说明。如无特别说明,所用化工原料均可从市场购买。本领域技术人员可以理解,下述实施例只是示例性的。In the following, the present application will be further described and illustrated in conjunction with the embodiments. Unless otherwise specified, all chemical raw materials used can be purchased from the market. Those skilled in the art can understand that the following embodiments are only exemplary.
实施例1Example 1
本实施例的合成路线如下所示:The synthetic route of the present embodiment is as follows:
在下文中,所用核磁共振波谱仪为布鲁克500M核磁共振波谱仪。In the following, the nuclear magnetic resonance spectrometer used is a Bruker 500M nuclear magnetic resonance spectrometer.
在下述核磁数据中,1H NMR(CDCl3,400MHz)表示以氘代氯仿为溶剂,400MHz下的核磁共振氢谱。1H NMR(DMSO-d6,500MHz)表示以氘代DMSO为溶剂,500MHz下的核磁共振氢谱。In the following nuclear magnetic data, 1 H NMR (CDCl 3 , 400 MHz) means hydrogen nuclear magnetic resonance spectrum at 400 MHz with deuterated chloroform as a solvent. 1 H NMR (DMSO-d6, 500MHz) means hydrogen nuclear magnetic resonance spectrum at 500MHz using deuterated DMSO as solvent.
步骤1:1-硝基-4-苯基乙炔苯的合成Step 1: Synthesis of 1-nitro-4-phenylethynylbenzene
将4-硝基碘苯12.5g(50mmol)、苯乙炔6.5mL(60mmol)、醋酸钯112.3mg(0.5mmol)、碘化亚酮95.3mg(0.5mmol)、Xantphos(289.3mg(0.5mmol)CAS:161265-03-8)、碳酸铯32.6g(100mmol)溶解于200mL N,N-二甲基甲酰胺中。加热至60℃搅拌16h。薄层色谱(TLC)监测反应结束,向体系中加入200mL蒸馏水淬灭。乙酸乙酯(200mL*2)萃取,饱和食盐水(200mL*2)洗涤有机相。无水硫酸镁干燥,旋转蒸干,柱层析分离得到10.47g(产率为94%)黄色固体粉末。对产物进行氢谱核磁共振表征,谱图如图1所示,核磁峰数据如下:12.5g (50mmol) of 4-nitroiodobenzene, 6.5mL (60mmol) of phenylacetylene, 112.3mg (0.5mmol) of palladium acetate, 95.3mg (0.5mmol) of ketone iodide, Xantphos (289.3mg (0.5mmol) CAS : 161265-03-8), cesium carbonate 32.6g (100mmol) was dissolved in 200mL N,N-dimethylformamide. Heated to 60°C and stirred for 16h. The end of the reaction was monitored by thin layer chromatography (TLC), and 200 mL of distilled water was added to the system to quench it. Extract with ethyl acetate (200mL*2), and wash the organic phase with saturated brine (200mL*2). It was dried over anhydrous magnesium sulfate, evaporated to dryness by rotary evaporation, and separated by column chromatography to obtain 10.47 g (yield rate: 94%) of yellow solid powder. The product was characterized by proton nuclear magnetic resonance, the spectrogram is shown in Figure 1, and the nuclear magnetic peak data are as follows:
1H NMR(CDCl3,400MHz):δ8.23(d,J=8.84Hz,2H),7.67(d,J=8.88Hz,2H),7.58-7.55(m,2H),7.40-7.39(m,3H)。 1 H NMR (CDCl 3 , 400MHz): δ8.23(d, J=8.84Hz, 2H), 7.67(d, J=8.88Hz, 2H), 7.58-7.55(m, 2H), 7.40-7.39(m ,3H).
步骤2:4-硝基苯偶酰的合成Step 2: Synthesis of 4-nitrobenzil
将1-硝基-4-苯基乙炔苯8.9g(40mmol)均匀溶解于250mL二甲基亚砜中再加入二氯化钯709.3mg(4mmol)。加热至145℃搅拌4h。薄层色谱(TLC)监测反应结束,向体系中加入250mL蒸馏水淬灭。乙酸乙酯(150ml*2)萃取,饱和食盐水(100ml*2)洗涤有机相。无水硫酸镁干燥,旋转蒸干,柱层析分离得到8.78g(产率为86%)黄色固体粉末。对产物进行氢谱核磁共振表征,谱图如图2所示,核磁峰数据如下:8.9 g (40 mmol) of 1-nitro-4-phenylethynylbenzene was uniformly dissolved in 250 mL of dimethyl sulfoxide, and 709.3 mg (4 mmol) of palladium dichloride was added. Heated to 145°C and stirred for 4h. The completion of the reaction was monitored by thin layer chromatography (TLC), and 250 mL of distilled water was added to the system to quench it. Extract with ethyl acetate (150ml*2), and wash the organic phase with saturated brine (100ml*2). Dry over anhydrous magnesium sulfate, rotary evaporate to dryness, and separate by column chromatography to obtain 8.78 g (86% yield) of yellow solid powder. The product was characterized by proton nuclear magnetic resonance, the spectrogram is shown in Figure 2, and the nuclear magnetic peak data are as follows:
1H NMR(CDCl3,400MHz):δ8.36(d,J=8.28Hz,2H),8.17(d,J=7.72Hz,2H),7.99(d,J=7.28Hz,2H),7.73-7.70(m,1H),7.58-7.54(m,2H)。 1 H NMR (CDCl 3 , 400MHz): δ8.36(d, J=8.28Hz, 2H), 8.17(d, J=7.72Hz, 2H), 7.99(d, J=7.28Hz, 2H), 7.73- 7.70 (m, 1H), 7.58-7.54 (m, 2H).
步骤3:2-(4-硝基苯基)-3-苯基-6-硝基喹喔啉和3-(4-硝基苯基)-2-苯基-6-硝基喹喔啉混合物的合成Step 3: 2-(4-Nitrophenyl)-3-phenyl-6-nitroquinoxaline and 3-(4-nitrophenyl)-2-phenyl-6-nitroquinoxaline Synthesis of the mixture
常温常压下将4-硝基苯偶酰6.7g(26mmol)、4-硝基邻苯二胺4.0g(26mmol)和糖精241mg(1.3mmol)均匀溶解于250mL冰醋酸中。室温下搅拌1h。薄层色谱(TLC)监测反应结束,向体系中加入250mL蒸馏水淬灭。过滤,蒸馏水洗三次,干燥,得到9.49g(产率为98%)黄色固体粉末。对产物进行氢谱核磁共振表征(包含两个同分异构体的混合物),谱图如图3所示,核磁峰数据如下:Under normal temperature and pressure, 6.7 g (26 mmol) of 4-nitrobenzil, 4.0 g (26 mmol) of 4-nitro-o-phenylenediamine and 241 mg (1.3 mmol) of saccharin were uniformly dissolved in 250 mL of glacial acetic acid. Stir at room temperature for 1 h. The completion of the reaction was monitored by thin layer chromatography (TLC), and 250 mL of distilled water was added to the system to quench it. Filter, wash with distilled water three times, and dry to obtain 9.49 g (98% yield) of yellow solid powder. The product is characterized by proton NMR (comprising a mixture of two isomers), the spectrogram is as shown in Figure 3, and the NMR peak data are as follows:
1H NMR(CDCl3,400MHz):δ9.10(1H),8.59-8.56(1H),8.34-8.32(1H),8.24-8.22(2H),7.78-7.75(2H),7.54-7.39(5H)。 1 H NMR (CDCl 3 , 400MHz): δ9.10(1H), 8.59-8.56(1H), 8.34-8.32(1H), 8.24-8.22(2H), 7.78-7.75(2H), 7.54-7.39(5H ).
步骤4:2-(4-氨基苯基)-3-苯基-6-氨基喹喔啉和3-(4-氨基苯基)-2-苯基-6-氨基喹喔啉混合物的合成Step 4: Synthesis of a mixture of 2-(4-aminophenyl)-3-phenyl-6-aminoquinoxaline and 3-(4-aminophenyl)-2-phenyl-6-aminoquinoxaline
将硝基混合物9g(24mmol)均匀溶解于250mL甲醇中再加入5%钯碳0.9g。接氢气袋置换三次氢气后于一个大气压下室温搅拌12h。薄层色谱(TLC)监测反应结束,硅藻土过滤,回收钯碳。浓缩滤液,甲醇重结晶,得到5.85g(产率为78%)黄色固体粉末。对产物进行氢谱核磁共振表征(包含两个同分异构体的混合物),谱图如图4所示,核磁峰数据如下:9 g (24 mmol) of the nitro mixture was uniformly dissolved in 250 mL of methanol, and 0.9 g of 5% palladium carbon was added. After replacing the hydrogen three times with a hydrogen bag, the mixture was stirred at room temperature for 12 hours under an atmospheric pressure. Thin-layer chromatography (TLC) monitored the completion of the reaction, filtered through diatomaceous earth, and recovered palladium carbon. The filtrate was concentrated and recrystallized from methanol to obtain 5.85 g (78% yield) of yellow solid powder. The product is characterized by proton NMR (comprising a mixture of two isomers), the spectrogram is as shown in Figure 4, and the NMR peak data are as follows:
1H NMR(DMSO-d6,500MHz):δ7.74-7.71(1H),7.45-7.41(2H),7.37-7.33(3H),7.23-7.16(1H),7.12-7.06(2H),6.94-6.92(1H),6.47-6.44(2H),6.02-5.98(2H),5.36-5.27(2H)。 1 H NMR (DMSO-d6, 500MHz): δ7.74-7.71(1H), 7.45-7.41(2H), 7.37-7.33(3H), 7.23-7.16(1H), 7.12-7.06(2H), 6.94- 6.92 (1H), 6.47-6.44 (2H), 6.02-5.98 (2H), 5.36-5.27 (2H).
上述对实施例的描述是为了便于本技术领域的普通技术人员能理解和应用本申请。熟悉本领域技术的人员显然可以容易地对这些实施例做出各种修改,并把在此说明的一般原理应用到其它实施例中而不必付出创造性的劳动。因此,本申请不限于这里的实施例,本领域技术人员根据本申请披露的内容,在不脱离本申请范围和精神的情况下做出的改进和修改都本申请的范围之内。The above description of the embodiments is for those of ordinary skill in the art to understand and apply the present application. It will be apparent to those skilled in the art that various modifications to these embodiments can be easily made, and the general principles described here can be applied to other embodiments without creative efforts. Therefore, the present application is not limited to the embodiments here, and improvements and modifications made by those skilled in the art based on the contents disclosed in the present application without departing from the scope and spirit of the present application are within the scope of the present application.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910966508.XA CN110627732A (en) | 2019-10-12 | 2019-10-12 | A method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof |
CN202010678948.8A CN112538053B (en) | 2019-10-12 | 2020-07-15 | Method for synthesizing nitroquinoxaline or derivative thereof and aminoquinoxaline or derivative thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910966508.XA CN110627732A (en) | 2019-10-12 | 2019-10-12 | A method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110627732A true CN110627732A (en) | 2019-12-31 |
Family
ID=68976116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910966508.XA Pending CN110627732A (en) | 2019-10-12 | 2019-10-12 | A method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110627732A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573517A (en) * | 2022-03-10 | 2022-06-03 | 新乡医学院 | Quinoxaline compound and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102241637A (en) * | 2011-06-29 | 2011-11-16 | 泰山医学院 | 2,3-diphenyl-6-amido quinoxaline compound and preparation method thereof |
CN105153144A (en) * | 2015-09-01 | 2015-12-16 | 哈尔滨工程大学 | Main-chain diamine type quinoxalinyl benzoxazine and preparation method thereof |
-
2019
- 2019-10-12 CN CN201910966508.XA patent/CN110627732A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102241637A (en) * | 2011-06-29 | 2011-11-16 | 泰山医学院 | 2,3-diphenyl-6-amido quinoxaline compound and preparation method thereof |
CN105153144A (en) * | 2015-09-01 | 2015-12-16 | 哈尔滨工程大学 | Main-chain diamine type quinoxalinyl benzoxazine and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
FRÉDÉRIC LASSAGNE ET AL.: "Saccharin as an Organocatalyst for Quinoxalines and Pyrido[2,3-b]pyrazines Syntheses", 《SYNTHETIC COMMUNICATIONS》 * |
SHIGEKI MORI ET AL.: "Palladium on carbon-catalyzed synthesis of benzil derivatives from 1,2-diarylalkynes with DMSO and molecular oxygen as dual oxidants", 《ADVANCED SYNTHESIS & CATALYSIS》 * |
王琳琳 等: "一锅法合成喹喔啉衍生物", 《贵州师范大学学报 (自然科学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573517A (en) * | 2022-03-10 | 2022-06-03 | 新乡医学院 | Quinoxaline compound and preparation method and application thereof |
CN114573517B (en) * | 2022-03-10 | 2024-04-26 | 新乡医学院 | Quinoxaline compound and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107382821B (en) | A kind of synthetic method of β-iodo-N-alkoxy amine compound | |
CN103601680A (en) | Bispyrazolyl energetic compounds and preparation method thereof | |
CN110183378B (en) | Nicotinamide derivative and catalytic synthesis method thereof | |
CN106188009A (en) | 3,4 dinitro 1 (1H tetrazolium 5 base) 1H pyrazoles 5 amine are containing energy ion salt preparation method and performance | |
CN110437172A (en) | A kind of 3,7- bis- replaces phenoxazine analog derivative and preparation method thereof | |
CN107200705A (en) | A kind of preparation method of the indolone derivatives of 3 nitro 2 | |
CN103342649A (en) | 3-amino-2, 4, 6-trinitro-distyrene compounds and preparation method thereof | |
CN106854165B (en) | A kind of preparation method of the bis- halogenated m-dicyanobenzenes of 4,6- | |
WO2020155925A1 (en) | Nitroalkyl quinoxaline or derivative thereof, aminoalkyl quinoxaline or derivative thereof, and synthesis method therefor | |
CN110627732A (en) | A method for synthesizing nitroquinoxaline or derivatives thereof and aminoquinoxaline or derivatives thereof | |
CN107573264A (en) | A kind of preparation technology of the sulfonic acid chloride of 3 cyano group, 5 methoxybenzene 1 | |
CN101985424B (en) | A kind of method of synthesizing o-nitroacetophenone compound | |
CN110305018A (en) | A kind of preparation method of 3-bromo-2-fluoronitrobenzene | |
CN102180877B (en) | Synthetic process of imidazo phenanthroline compound | |
CN107602570A (en) | A kind of nitrogenous polynary and heterocyclic compound method of synthesis | |
CN105693632B (en) | A kind of preparation method of polysubstituted quinoxaline derivant | |
CN104610262A (en) | Biphenyl compound, intermediate, preparation method, pharmaceutical composition, and applications of biphenyl compound and pharmaceutical composition | |
CN103232397B (en) | The synthetic method of 5-amino-N-substituted benzimidazole ketone | |
CN105566235B (en) | The method of the substep synthesis triazoles of NH 1,2,3 is catalyzed using aluminium salt | |
CN104119286A (en) | Condensed triazole benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof | |
CN111057010B (en) | Method for synthesizing benzimidazole compound by copper catalysis | |
CN109970676A (en) | Trinitrethylaminobifurazan and its synthesis method | |
CN107382771A (en) | The synthetic method of aromatic nitrile compounds | |
CN111848527A (en) | A kind of 4-chloro-2-(2-fluoro-4-methoxyphenyl)-6-methoxyquinazoline and its synthetic method | |
CN108586369B (en) | Preparation method of phenyltriazine compound and preparation method of phenylpyridine compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191231 |